1-20 of 28
Authors: Brigitte Bader-Meunier
Save search
Sort by
Journal Article
ACCEPTED MANUSCRIPT

Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohort Get access

PDF
Jade Cognard and others
Rheumatology, keaf231, https://doi.org/10.1093/rheumatology/keaf231
Published: 25 April 2025
Journal Article

Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers Get access

PDF
Matthew A Sherman and others
Rheumatology, keaf086, https://doi.org/10.1093/rheumatology/keaf086
Published: 10 February 2025
Journal Article

Comment on: Long-term outcomes of childhood-onset systemic lupus erythematosus: Reply Get access

PDF
Brigitte Bader-Meunier and others
Rheumatology, keae508, https://doi.org/10.1093/rheumatology/keae508
Published: 04 October 2024
Journal Article

Long-term outcomes of childhood-onset systemic lupus erythematosus Get access

PDF
Anne Mirguet and others
Rheumatology, Volume 64, Issue 4, April 2025, Pages 2209–2213, https://doi.org/10.1093/rheumatology/keae344
Published: 15 July 2024
Journal Article

TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients

PDF
Huong D Nguyen and others
Rheumatology, Volume 63, Issue 10, October 2024, Pages e281–e284, https://doi.org/10.1093/rheumatology/keae182
Published: 18 March 2024
Journal Article

Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?

PDF
Brigitte Bader-Meunier and others
Rheumatology, Volume 62, Issue 8, August 2023, Pages e242–e245, https://doi.org/10.1093/rheumatology/keac696
Published: 02 January 2023
Journal Article

Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study

PDF
Imène Dabbak and others
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4514–4520, https://doi.org/10.1093/rheumatology/keac107
Published: 23 February 2022
Journal Article

Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial

PDF
Jerold Jeyaratnam and others
Rheumatology, Volume 61, Issue 5, May 2022, Pages 2088–2094, https://doi.org/10.1093/rheumatology/keab696
Published: 23 September 2021
Journal Article

JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study

PDF
Tom Le Voyer and others
Rheumatology, Volume 60, Issue 12, December 2021, Pages 5801–5808, https://doi.org/10.1093/rheumatology/keab116
Published: 12 February 2021
Journal Article

Rheumatoid factor positive polyarticular juvenile idiopathic arthritis associated with a novel COPA mutation

PDF
Brigitte Bader-Meunier and others
Rheumatology, Volume 60, Issue 5, May 2021, Pages e171–e173, https://doi.org/10.1093/rheumatology/keaa763
Published: 02 December 2020
Journal Article

European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative

PDF
Nienke de Graeff and others
Rheumatology, Volume 59, Issue 4, April 2020, Page 919, https://doi.org/10.1093/rheumatology/keaa057
Published: 19 February 2020
Journal Article

Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology

PDF
Cyril Gitiaux and others
Rheumatology, Volume 59, Issue 5, May 2020, Page 1191, https://doi.org/10.1093/rheumatology/kez687
Published: 23 January 2020
Journal Article

Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling Get access

PDF
Isabelle Melki and others
Rheumatology, Volume 59, Issue 8, August 2020, Pages 1927–1937, https://doi.org/10.1093/rheumatology/kez525
Published: 22 November 2019
Journal Article

Comment on: Monogenic mimics of Behçet’s disease in the young Get access

PDF
Florence A Aeschlimann and others
Rheumatology, Volume 59, Issue 11, November 2020, Pages e109–e111, https://doi.org/10.1093/rheumatology/kez543
Published: 14 November 2019
Journal Article

Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology Get access

PDF
Cyril Gitiaux and others
Rheumatology, Volume 59, Issue 5, May 2020, Pages 1171–1174, https://doi.org/10.1093/rheumatology/kez508
Published: 30 October 2019
Journal Article

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative Get access

PDF
Seza Ozen and others
Rheumatology, Volume 58, Issue 9, September 2019, Pages 1607–1616, https://doi.org/10.1093/rheumatology/kez041
Published: 16 March 2019
Journal Article

European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative Get access

PDF
Nienke de Graeff and others
Rheumatology, Volume 58, Issue 4, April 2019, Pages 656–671, https://doi.org/10.1093/rheumatology/key322
Published: 07 December 2018
Journal Article

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative Get access

PDF
Nienke de Graeff and others
Rheumatology, Volume 58, Issue 4, April 2019, Pages 672–682, https://doi.org/10.1093/rheumatology/key344
Published: 07 December 2018
Journal Article

S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome Get access

PDF
Lin Wang and others
Rheumatology, Volume 57, Issue 7, July 2018, Pages 1299–1304, https://doi.org/10.1093/rheumatology/key090
Published: 07 April 2018
Journal Article

Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis Get access

PDF
Jessie Aouizerate and others
Rheumatology, Volume 57, Issue 5, May 2018, Pages 873–879, https://doi.org/10.1093/rheumatology/kex516
Published: 20 February 2018